Robert MacLaren, an ophthalmologist at the University of Oxford led the study. “When retinal damage gets to a certain point, it’s beyond repair.”
Gene Trial Makes Eye Disease Breakthrough
The experimental treatment adds a working copy of the culpable gene to the retinal cells of the patients born with a defective copy. The trial also involved an experimental way of delivering gene therapy to the eye. Each patient's retina was first lifted, and the gene therapy was injected into the space created under the retina. MacLaren and colleagues report on the condition of six patients in a study published on 16th January in the Lancet.
No comments:
Post a Comment